Haiqiang Cao
State Key Laboratory Of Drug Research & Center Of Pharmaceutics
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Research progress and development strategies of antibody-oligonucleotide conjugates.
Journal: Gene therapy
Published: October 29, 2025
Nanotechnology used for siRNA delivery for the treatment of neurodegenerative diseases: Focusing on Alzheimer's disease and Parkinson's disease.
Journal: International journal of pharmaceutics
Published: June 19, 2024
Recent Progress of Small Interfering RNA Delivery on the Market and Clinical Stage.
Journal: Molecular pharmaceutics
Published: April 17, 2024
Oxaliplatin lipidated prodrug synergistically enhances the anti-colorectal cancer effect of IL12 mRNA.
Journal: Drug delivery and translational research
Published: February 08, 2024
Drug development advances in human genetics-based targets.
Journal: MedComm
Published: August 23, 2023
Recent advances in developing active targeting and multi-functional drug delivery systems via bioorthogonal chemistry.
Journal: Signal transduction and targeted therapy
Published: August 03, 2022
Walking Dead Tumor Cells for Targeted Drug Delivery Against Lung Metastasis of Triple-Negative Breast Cancer.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: June 16, 2022
Phospholipid membrane-decorated deep-penetrated nanocatalase relieve tumor hypoxia to enhance chemo-photodynamic therapy.
Journal: Acta pharmaceutica Sinica. B
Published: March 13, 2020
Corrigendum to "Apoferritin nanocages loading mertansine enable effective eradiation of cancer stem-like cells in vitro" [Int. J. Pharm. 553 (2018) 201-209].
Journal: International journal of pharmaceutics
Published: January 27, 2020
Orally delivered legumain-activated nanovehicles improve tumor accumulation and penetration for combinational photothermal-chemotherapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: December 11, 2019
Correction to Codelivery of Sorafenib and Curcumin by Directed Self-Assembled Nanoparticles Enhances Therapeutic Effect on Hepatocellular Carcinoma.
Journal: Molecular pharmaceutics
Published: December 06, 2019
Last Updated: 09/26/2026